Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
For women with endometrial cancer of high-intermediate risk, adjuvant therapy should be vaginal brachytherapy instead of external beam radiation therapy. Medscape Medical News